Resources

Instant Insights – CRISPR

Home | Resources

Prescriber Perceptions around CRISPR in 2023

Four years ago, InCrowd assessed the awareness among physicians of nucleic acid-based therapies, their mechanisms of action, and their current and future promise.
In considering the 2019 research, InCrowd wanted to understand any change in awareness of these therapies and then examine specific perceptions around CRISPR. This research reflects the comparisons of awareness between 2019 and 2023 of nucleic acid-based therapies with a specific focus on CRISPR.

Our 2023 report includes responses from over 100 qualified US-based healthcare professionals (HCPs) familiar with the therapies considered in the research.

Explore respondents’:

  • Awareness of CRISPR and mRNA
  • Optimism and concerns regarding the widespread use of CRISPR
  • Comfort level recommending and administering CRISPR to patients

Get our key takeaways. Download the report today.

Please fill out the form below to access this content

Related Resources

2025 State of Healthcare Report: April 

2025 State of Healthcare Report: April 

Timely insights from patients and healthcare providers on the impact of policy changes, cost shifts, and access challenges. From rising out-of-pocket costs to concerns over Medicare and Medicaid, the U.S. healthcare landscape is in flux, and patients and providers are...

read more
IV Fluid Supply Chain Disruptions 

IV Fluid Supply Chain Disruptions 

Discover the Impact of Hurricane Helene on IV Fluid Availability When Hurricane Helene disrupted a key IV fluid manufacturing facility in the southeastern US, healthcare systems felt the ripple effects. InCrowd conducted research to uncover how this shortage has...

read more
Physician Burnout: Knowing Your Audience 

Physician Burnout: Knowing Your Audience 

Physician Engagement in a Time of Accelerated Professional Burnout  As burnout remains a significant challenge for healthcare professionals (HCPs), emerging research indicates a potential shift in this landscape. Our newest report unveils insights from a recent...

read more